Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesotheliomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03805971
What this trial is testing

Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Malignancies Diagnosis.

Who this might be right for
Pleural Carcinomatosis
University of Liege 65
Testing effectiveness (Phase 2)Study completedNCT00137826
What this trial is testing

Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma

Who this might be right for
Mesothelioma
Dana-Farber Cancer Institute 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07514793
What this trial is testing

Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma

Who this might be right for
Mesothelioma
Fudan University 37
Large-scale testing (Phase 3)Ended earlyNCT01604005
What this trial is testing

PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Brynn Chappell 375
Testing effectiveness (Phase 2)Study completedNCT02860286
What this trial is testing

Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma

Who this might be right for
MesotheliomaBAP1 Loss of Function
Epizyme, Inc. 74
Early research (Phase 1)UnknownNCT02637531
What this trial is testing

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Who this might be right for
Advanced Solid Tumors (Part A/B/C/D)Non-small Cell Lung Cancer (Part E)Melanoma (Part E)+5 more
Infinity Pharmaceuticals, Inc. 219
Not applicableWithdrawnNCT01325753
What this trial is testing

Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body

Who this might be right for
Advanced Malignant MesotheliomaExtensive Stage Small Cell Lung CancerLung Metastases+4 more
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Ended earlyNCT01583686
What this trial is testing

CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer

Who this might be right for
Cervical CancerPancreatic CancerOvarian Cancer+2 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00107432
What this trial is testing

Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.

Who this might be right for
Epithelial MesotheliomaRecurrent Malignant MesotheliomaSarcomatous Mesothelioma+5 more
National Cancer Institute (NCI) 44
Early research (Phase 1)Ended earlyNCT01445392
What this trial is testing

SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT01766739
What this trial is testing

Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 18
Early research (Phase 1)Ended earlyNCT02707666
What this trial is testing

A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
University of Chicago 7
Early research (Phase 1)Ended earlyNCT04836429
What this trial is testing

Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease

Who this might be right for
Lung Non-Small Cell CarcinomaPleural Disorder
Roswell Park Cancer Institute 5
Early research (Phase 1)Study completedNCT00413322
What this trial is testing

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Who this might be right for
Tumor
Valerio Therapeutics 35
Testing effectiveness (Phase 2)Study completedNCT03213301
What this trial is testing

Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.

Who this might be right for
Malignant Pleural Mesothelioma, Advanced
Swiss Cancer Institute 42
Early research (Phase 1)Study completedNCT03071757
What this trial is testing

The Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 139
Testing effectiveness (Phase 2)Study completedNCT00407459
What this trial is testing

Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Armando Santoro, MD 77
Testing effectiveness (Phase 2)Study completedNCT03207347
What this trial is testing

A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)

Who this might be right for
MesotheliomaUveal MelanomaRenal Cell Carcinoma+1 more
University of Florida 37
Testing effectiveness (Phase 2)Ended earlyNCT05451849
What this trial is testing

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more
TCR2 Therapeutics 14
Testing effectiveness (Phase 2)Ended earlyNCT00895648
What this trial is testing

Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma

Who this might be right for
MesotheliomaPleural Mesothelioma
University Health Network, Toronto 6
Next Page